The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC

ObjectiveTo investigate the value of Fluorine-18 Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) combined with 3D quantitative technology and clinicopathological features in predicting the prognosis of non-small cell lung cancer (NSCLC).MethodsA retrospective r...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuling Su, Siwen Qiu, Jinyu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1533569/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850216055602937856
author Yuling Su
Siwen Qiu
Jinyu Wang
author_facet Yuling Su
Siwen Qiu
Jinyu Wang
author_sort Yuling Su
collection DOAJ
description ObjectiveTo investigate the value of Fluorine-18 Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) combined with 3D quantitative technology and clinicopathological features in predicting the prognosis of non-small cell lung cancer (NSCLC).MethodsA retrospective review was performed for patients who underwent PET/CT and curative resection of NSCLC between January 2016 and June 2019 in our hospital. PET/CT data, clinical features, and pathology results were collected. Gross tumor volume (GTV) was delineated on CT images by ITK-SNAP software. The prognosis was followed up, and the study endpoint was progression-free survival (PFS). Receiver operating characteristic curve (ROC) was used to initially assess the relationship between each parameter and PFS, and parameters were grouped accordingly. Cox proportional hazards regression was used to develop models based on clinicopathological features to predict prognosis of NSCLC patients. Kaplan–Meier method was used to draw the survival curves.ResultsA total of 128 patients were enrolled in the study with PFS of 8–96 months. Univariate analysis demonstrated that age, SUVindex (the ratio of SUVmax of lesion to SUVmax of liver), metabolic tumor volume (MTV), Dmax (the largest diameter), GTV, lymph node metastasis (LNM), and TNM staging are significantly related to recurrence (all p<0.05). The multivariate analysis showed that only age, SUVindex, and LNM were independent prognostic factor for PFS (all p < 0.05).ConclusionsAlthough 18F-FDG PET/CT combined with 3D quantitative technique were helpful in predicting PFS in NSCLC, only age, SUVindex, and LNM were independent predictors for PFS.
format Article
id doaj-art-3dd6ed6948034fffb68fefe3d3ce25a8
institution OA Journals
issn 2234-943X
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-3dd6ed6948034fffb68fefe3d3ce25a82025-08-20T02:08:25ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-04-011510.3389/fonc.2025.15335691533569The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLCYuling SuSiwen QiuJinyu WangObjectiveTo investigate the value of Fluorine-18 Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) combined with 3D quantitative technology and clinicopathological features in predicting the prognosis of non-small cell lung cancer (NSCLC).MethodsA retrospective review was performed for patients who underwent PET/CT and curative resection of NSCLC between January 2016 and June 2019 in our hospital. PET/CT data, clinical features, and pathology results were collected. Gross tumor volume (GTV) was delineated on CT images by ITK-SNAP software. The prognosis was followed up, and the study endpoint was progression-free survival (PFS). Receiver operating characteristic curve (ROC) was used to initially assess the relationship between each parameter and PFS, and parameters were grouped accordingly. Cox proportional hazards regression was used to develop models based on clinicopathological features to predict prognosis of NSCLC patients. Kaplan–Meier method was used to draw the survival curves.ResultsA total of 128 patients were enrolled in the study with PFS of 8–96 months. Univariate analysis demonstrated that age, SUVindex (the ratio of SUVmax of lesion to SUVmax of liver), metabolic tumor volume (MTV), Dmax (the largest diameter), GTV, lymph node metastasis (LNM), and TNM staging are significantly related to recurrence (all p<0.05). The multivariate analysis showed that only age, SUVindex, and LNM were independent prognostic factor for PFS (all p < 0.05).ConclusionsAlthough 18F-FDG PET/CT combined with 3D quantitative technique were helpful in predicting PFS in NSCLC, only age, SUVindex, and LNM were independent predictors for PFS.https://www.frontiersin.org/articles/10.3389/fonc.2025.1533569/fulllung cancerPET/CTprognosis3D quantitative technologyNSCLC
spellingShingle Yuling Su
Siwen Qiu
Jinyu Wang
The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC
Frontiers in Oncology
lung cancer
PET/CT
prognosis
3D quantitative technology
NSCLC
title The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC
title_full The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC
title_fullStr The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC
title_full_unstemmed The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC
title_short The value of 18F-FDG PET/CT combined with 3D quantitative technology and clinicopathological features in predicting prognosis of NSCLC
title_sort value of 18f fdg pet ct combined with 3d quantitative technology and clinicopathological features in predicting prognosis of nsclc
topic lung cancer
PET/CT
prognosis
3D quantitative technology
NSCLC
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1533569/full
work_keys_str_mv AT yulingsu thevalueof18ffdgpetctcombinedwith3dquantitativetechnologyandclinicopathologicalfeaturesinpredictingprognosisofnsclc
AT siwenqiu thevalueof18ffdgpetctcombinedwith3dquantitativetechnologyandclinicopathologicalfeaturesinpredictingprognosisofnsclc
AT jinyuwang thevalueof18ffdgpetctcombinedwith3dquantitativetechnologyandclinicopathologicalfeaturesinpredictingprognosisofnsclc
AT yulingsu valueof18ffdgpetctcombinedwith3dquantitativetechnologyandclinicopathologicalfeaturesinpredictingprognosisofnsclc
AT siwenqiu valueof18ffdgpetctcombinedwith3dquantitativetechnologyandclinicopathologicalfeaturesinpredictingprognosisofnsclc
AT jinyuwang valueof18ffdgpetctcombinedwith3dquantitativetechnologyandclinicopathologicalfeaturesinpredictingprognosisofnsclc